MetaCap

Helus Pharma (HELP) vs Zevra Therapeutics (ZVRA)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Helus Pharma (HELP) has outperformed Zevra Therapeutics (ZVRA) over the past year, gaining 9.3% versus a gain of 1.9%. Over five years, ZVRA leads with a +8.8% price change compared with -88.1% for HELP. Zevra Therapeutics is the larger company by market cap ($521.3 million vs $487.7 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

HELP+9.30%ZVRA+1.86%
+160%+60%-40%
Nov 21, 20251 yearNov 20, 2026
HELP-90.14%ZVRA+4.29%
+74%-13%-101%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

HELP versus ZVRA key metrics
MetricHELPZVRA
Share price$6.11$8.76
Market cap$487.68M$521.26M
1-day change-9.88%-3.42%
YTD return-25.31%-2.23%
1-year return+9.30%+1.86%
5-year return-88.09%+8.82%
P/E ratio (TTM)—7.18
Forward P/E—9.84
EPS (TTM)$-4.25$1.22
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$106.47M
Revenue growth (YoY)—+350.91%
Net income (latest FY)—$83.23M
Gross margin—84.52%
Operating margin—-59.12%
Net margin—78.17%
52-week high$15.15$15.04
52-week low$3.76$8.01
Distance from 52-week high-59.67%-41.74%
Analyst consensusnonestrong_buy
Avg. price target upside+564.81%+162.56%
Average volume1.83M954.53K
Shares outstanding79.81M59.50M
Employees10061
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Helus Pharma

HELP stock →

Helus Pharma Inc. operates as a clinical stage pharmaceutical company that focuses on developing therapies to treat psychiatric and neurological conditions.

Health Care · Biotechnology: Pharmaceutical Preparations · 100 employees

About Zevra Therapeutics

ZVRA stock →

Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform.

Health Care · Biotechnology: Pharmaceutical Preparations · 61 employees

HELP vs ZVRA FAQ

Which is bigger, Helus Pharma or Zevra Therapeutics?

Zevra Therapeutics (ZVRA) is larger, with a market capitalization of $521.26M compared with $487.68M for Helus Pharma (HELP).

Which stock has performed better over the past year, HELP or ZVRA?

HELP returned +9.30% over the past 12 months, compared with +1.86% for ZVRA (price return, excluding dividends). Past performance does not predict future results.

Are Helus Pharma and Zevra Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons